Version2 Technology, Inc. v. NeilMed Pharmaceuticals, Inc. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Version2 Technology, Inc. v. NeilMed Pharmaceuticals, Inc.

Sort by

Viewing results 1‒10 of 10

Coronavirus treatment
EU fast-tracks process for Pfizer and BioNTech’s Covid-19 vaccine
...Mainz-based BioNTech, whose vaccine relies on mRNA technology, stressed that the speeded-up process by the EMA would not dilute the regulator’s safety standards....
October 6, 2020
The Long ViewMichael Mackenzie
The coming earnings season could bring lofty stocks down to earth
...According to Morgan Stanley Wealth Management, the sectors that have benefited the most from low taxes and the use of offshore locations are technology and pharmaceuticals — two of the stronger recent performers...
July 11, 2020
FT Live
Global Private Banking Awards 2024
Celebrating excellence in wealth management
Thursday, 7 NovemberThe Landmark London, London, UK
News in-depthPharmaceuticals sector
Crispr puts first human in-body gene editing to test
...Beyond these three biotechs, Crispr could end up transforming the entire pharmaceutical industry....
January 7, 2020
News in-depthThe Big Read
Quantum computing: the power to think outside the box
...Pharmaceutical groups, which might see similar benefits from quantum technology in the long term, are still on the sidelines....
September 3, 2018
News in-depthThe Big Read
Big Tech vs Big Pharma: the battle over US patent protection
...Thanks to a series of court rulings since the mid-2000s, such as eBay v MercExchange in 2007, Mayo Collaborative Services v Prometheus Laboratories in 2012 and Alice Corp v CLS Bank in 2014, and the subsequent...
October 16, 2017
News in-depthThe Big Read
Samsung: The activist v the ‘owners’
...Aberdeen Asset Management and Canada Pension Plan have also voiced opposition to the deal, as has the local company Ilsung Pharmaceuticals, which holds 2 per cent....
July 15, 2015
FT Live
FTWeekend Festival: U.S. edition
Where the Financial Times weekend paper comes to life
Saturday, 4 MayThe REACH, at the Kennedy Center for the Performing Arts, F Street Northwest, Washington, DC, USA
FT AlphavilleDavid Keohane
The 6am London Cut
...(Financial Times) Roche is to buy Santaris Pharma for up to $450m in the latest piece of dealmaking by the Swiss pharmaceuticals group....
August 5, 2014
New Technology Policy ForumTechnology sector
A dangerous one-two punch
...He has consulted frequently on both pharmaceutical and high tech issues....
October 24, 2007
News in-depthCompanies
Get it now from Ebay, hostage to the patent trolls
...That is the issue before the Supreme Court on March 29 in Ebay v MercExchange: should courts have discretion to consider the big picture or just grant, in almost every instance, an injunction that can shut...
March 15, 2006
US politics & policy
Supreme Court poised to take up patent law reform
...The pharmaceutical industry favours mandatory injunctions. But the US technology industry is hit hard by such moves, since many of its products rely on thousands of different technologies....
November 10, 2005

Previous pagePage 1 of 1Next page